Related Experiment Video
Updated: Dec 7, 2025

Knee Arthrocentesis in Adults
Published on: February 25, 2022
The Preferred Treatment of Sternoclavicular Joint Infections: A Systematic Review
Barkat Ali1, Venus Barlas2, Anil K Shetty2
1Surgery, University of New Mexico Health Sciences Center, Albuquerque, USA.
Abstract:
The treatment of sternoclavicular joint infection is a topic of controversy. This systematic review aims to evaluate the preferred treatment of sternoclavicular joint infections. A literature search using PubMed/MEDLINE®/Embase databases was conducted to identify publications on the surgical management of sternoclavicular joint infections. Case reports and studies without surgical management were excluded. The outcomes of interest included patient demographics, comorbidities, infectious etiologies, radiographic features, surgical management, and complications. Sixteen articles met the inclusion criteria. The mean age of the subjects was 53.4 years; there was a predominance of males (65%), and a minority of the subjects were obese (15%). The most common infectious etiology was methicillin-susceptible Staphylococcus aureus (MSSA) (48%). CT scan was reported in 46% of cases. The most common treatment was surgical resection of the joints (85%), followed by muscle flap closure of the wounds (54.2%). The complication rate ranged from 0-40%. Specifically, recurrence of infection was low with resection of the joint, followed by muscle flap closure. Given the heterogeneity of the methodology and inconsistency in the outcomes, a meta-analysis could not be performed. Overall, the current literature favors the resection of the sternoclavicular joint as the gold standard treatment. Closure of the wound using muscle flap seems to adequately treat this problem without any major untoward events.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Tonsillitis II: Management
Pericarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management

